Centene Corp (CNC)

Currency in USD
76.03
+8.55(+12.66%)
Closed·
76.50+0.49(+0.64%)
·
Trading near 52-week High
CNC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
70.2177.05
52 wk Range
31.6377.05
Key Statistics
Prev. Close
67.48
Open
70.63
Day's Range
70.21-77.05
52 wk Range
31.63-77.05
Volume
13.27M
Average Volume (3m)
4.62M
1-Year Change
110.5511%
Book Value / Share
44.95
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
74.50
Downside
-2.01%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Centene Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

8 Buy
12 Hold
1 Sell
Ratings:
21 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 74.50
(-2.01% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Truist Securities
Buy82.00+7.85%80.00MaintainNov 02, 2026
Wells Fargo
Hold75.00-1.35%69.00MaintainOct 30, 2026
JPMorgan
Hold75.00-1.35%67.00MaintainOct 29, 2026
Jefferies
Hold69.00-9.25%59.00MaintainOct 29, 2026
Cantor Fitzgerald
Buy79.00+3.91%75.00MaintainOct 28, 2026

Centene Corp SWOT Analysis


Enrollment Decline
Centene faces a projected 6% Medicaid enrollment decline through 2026, with mid-4% attrition rates challenging the company's core business model and scale advantages
Medicare Strategy
The company pursues break-even status in Medicare Advantage amid prescription drug plan margin pressures creating a $0.74 negative earnings impact
Analyst Outlook
Cantor Fitzgerald maintains a Neutral rating with a $41 price target, reflecting cautious sentiment amid membership losses and profitability challenges
Market Position
Despite near-term headwinds, Centene's Medicaid expertise and government program relationships position the company to capitalize on demographic trends and potential enrollment stabilization
Read full SWOT analysis

Centene Corp Earnings Call Summary for Q3/2026

  • Centene Q3 adjusted EPS hit $0.58, crushing $0.10 estimate; revenue of $50.65B topped forecasts by 7.5%, driving shares up 2.49% premarket.
  • Full-year 2026 adjusted EPS guidance raised to above $5.20 from above $4.80, signaling sustained operational momentum across business lines.
  • Medicare Advantage on track for break-even in 2026, one year ahead of plan; Marketplace margins now targeting top of 4.5%-5% range.
  • Total debt cut to $15.0B from $18.5B at end-2024; operating cash flow reached $4.3B year-to-date despite quarterly timing headwinds.
  • Management expects 2027 EPS growth versus 2026, with Medicare improving beyond break-even and SG&A declining from optimization efforts.
Last Updated: 2026-10-27, 09:44 a/m
Read Full Transcript

Earnings

Latest Release
Oct 27, 2026
EPS / Forecast
0.58 / 0.10
Revenue / Forecast
50.65B / 47.11B
EPS Revisions
Last 90 days

CNC Income Statement

Compare CNC to Peers and Sector

Metrics to compare
CNC
Peers
Sector
Relationship
P/E Ratio
22.9x17.5x−0.3x
PEG Ratio
0.18−0.090.00
Price/Book
1.5x5.4x2.6x
Price / LTM Sales
0.2x0.6x2.8x
Upside (Analyst Target)
−2.0%18.8%67.2%
Fair Value Upside
Unlock12.8%10.1%Unlock

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
238.85M48.25%15.89B
Other Institutional Investors
254.30M51.37%16.92B
Public Companies & Retail Investors
1.91M0.39%127.40M
Total
495.07M100.00%32.94B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.8.37%41,446,0462,757,405
Vanguard Capital Management, LLC6.90%34,139,1602,271,278

People Also Watch

417.42
HUM
-0.11%
187.67
NTAP
-1.63%
85.89
AKAM
-0.74%
36.98
EFOR
+7.97%
354.00
COR
+3.96%

FAQ

What Is the Centene (CNC) Stock Price Today?

The Centene stock price today is 76.03 USD.

What Stock Exchange Does Centene Trade On?

Centene is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Centene?

The stock symbol for Centene is "CNC."

What Is the Centene Market Cap?

As of today, Centene market cap is 33.41B USD.

What Is Centene's Earnings Per Share (TTM)?

The Centene EPS (TTM) is 2.96.

When Is the Next Centene Earnings Date?

Centene will release its next earnings report on Feb 09, 2027.

From a Technical Analysis Perspective, Is CNC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Centene Stock Split?

Centene has split 4 times.

How Many Employees Does Centene Have?

Centene has 61100 employees.

What is the current trading status of Centene (CNC)?

As of Nov 04, 2026, Centene (CNC) is trading at a price of 76.03 USD, with a previous close of 67.48 USD. The stock has fluctuated within a day range of 70.21 USD to 77.05 USD, while its 52-week range spans from 31.63 USD to 77.05 USD.

What Is Centene (CNC) Price Target According to Analysts?

The average 12-month price target for Centene is 74.50 USD, with a high estimate of 85 USD and a low estimate of 56 USD. 8 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -2.01% Downside potential.

What Is the CNC Premarket Price?

CNC's last pre-market stock price is 70.38 USD. The pre-market share volume is 126,710.00, and the stock has decreased by 2.90, or 4.30%.

What Is the CNC After Hours Price?

CNC's last after hours stock price is 76.50 USD, the stock has decreased by 0.49, or 0.64%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.